socalTECH

SEPTEMBER 29, 2020

San Diego-based Seismic , which develops sales enablement and marketing software, has joined the unicorn club, saying this morning that it has raised $92M in a Series F funding, which values the company at approximately $1.6 Rowe Price, its existing investors. Seismic has now raised a total of $270M in funding.

San Diego 113

San Diego Sales Pricing Activity 113

socalTECH

SEPTEMBER 23, 2019

A portfolio company of San Diego-based biopharmaceuticals venture investor Versant Ventures is getting set for its IPO this week. Aprea Therapeutics said that estimates its IPO will price between $14.00 Aprea's investment bankers on the IPO are J.P. and $16.00 per share, which could raise as much as $92.0M

San Diego 113

San Diego Pricing Invest Marketing 113

socalTECH

AUGUST 29, 2018

San Diego-based Obalon Therapeutics , a publicly held developer of medical devices to treat obesity, has raised $10M in a private placement, the company said this week. The company said it 5,494,506 shares of common stock at a price of $1.82 per share in the offering. Obalon trades on the NASDAQ as OBLN.

San Diego 100

San Diego Pricing Invest Funding 100

Xconomy

FEBRUARY 1, 2019

Pharmaceutical companies typically raise prescription drug prices at the start of each year and this year was no different. The increases were the latest reminder that, despite President Trump’s fiery campaign rhetoric, the administration had done little to actually lower drug prices.

Pricing 84

Pricing Services Company Companies 84

socalTECH

OCTOBER 10, 2019

San Diego-based Mercato , which provides delivery of items from independently owned grocery and specialty food stores, has launched a new program that offers up unlimited free, same-day grocery delivery from local grocery stores. Mercato is led by founder and CEO Bobby Brannigan. Mercato is led by founder and CEO Bobby Brannigan.

San Diego 113

San Diego Pricing Funding Invest 113

Xconomy

OCTOBER 27, 2016

Prices for agricultural commodities such as corn, soy, and wheat are at their lowest levels in years, but investment in agricultural technology has never been better. The increase in dollars flowing to agtech comes despite commodity prices that are down 65 percent from their 2013 peak, the report says.

Venture Capital 40

Venture Capital Pricing Invest Report 40

socalTECH

JANUARY 26, 2017

San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has raised $75.0M Anaptys priced its IPO on Wednesday night at $15.00 AnaptysBio is backed by Frazier Healthcare, Novo A/S, Avalon Ventures, Alloy Ventures, Biotechnology Value Fund, HBM Healthcare Investments, and others. READ MORE>>.

Avalon 100

Avalon San Diego Pricing Invest 100

socalTECH

FEBRUARY 9, 2016

Orange County-based KGrid , a cleantech startup working on electric car charging stations, said it has received an investment from German utility RWE , via RWE New Ventures LLC. Financial terms of the investment were not announced. KnGrid was founded by Stephen G. Davis and David Hawkins. READ MORE>>.

Orange County 100

Orange County Funding San Diego Pricing 100

TechCrunch LA

MARCH 20, 2019

The feature illustrates how Postmates, one of the earlier entrants to the billion-dollar food delivery wars , is trying to remain competitive by appealing to price-sensitive customers. For now, the company’s party feature will only be offered in a handful of the nearly 3,000 U.S. cities in which it currently operates.

Orange County 200

Orange County Long Beach San Diego Los Angeles 200

socalTECH

MAY 7, 2015

San Diego-based biotech developer aTyr Pharma is debuting in its IPO this morning, after pricing its IPO at $14.00 the company will trade as LIFE on the NASDAQ Global Market starting this morning. The company raised $75M in the offering. per share last night.

San Diego 100

San Diego Pricing Invest Marketing 100

Xconomy

OCTOBER 26, 2018

In the biotech investment and research communities this week, much of the attention was turned to Europe. As with another Alzheimer’s meeting back in July , much of the interest there focused on data from a drug developed by Japanese pharmaceutical company Eisai and partner Biogen that has left.

Pricing 86

Pricing Conference Research Invest 86

Xconomy

JULY 13, 2018

Drug price changes typically happen either at the start of the calendar year or the beginning of the third quarter. Such changes are routine for many companies, but Pfizer took an unusual step this week by rolling back scheduled price increases on 40 of its drugs. In May, Trump and. Read more » Reprints | Share:

Pricing 56

Pricing Guide News Services 56

Xconomy

JULY 29, 2020

Thrive Earlier Detection, one of the companies vying to be the first to commercialize a blood test that can uncover cases of cancer before symptoms arise, has raised $257 million and announced plans to evaluate its CancerSEEK test in a registrational study. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

San Diego 87

San Diego Study Capital Invest 87

Xconomy

MAY 22, 2020

But the biotech sector is defying the pandemic with crossover financings and freshly minted public companies. On Friday, three firms added their names to the list of life science companies preparing to join the public markets. COVID-19 has ravaged the economy, and it was expected to quash the IPO market, too.

Company 145

Company Companies Marketing Develop 145

Xconomy

DECEMBER 18, 2018

Seismic, an enterprise software company with ambitious growth plans, has raised $100 million in a Series E financing and added Microsoft chairman John W. The venture investment, which the San Diego startup announced Tuesday, is one of only a few so-called mega-rounds—$100 million or more—recorded this year in the region.

Southern California 110

Southern California San Diego Software Invest 110

Xconomy

JANUARY 10, 2020

Six CEOs, including five who run public companies, co-authored the letter. A letter signed by 215 people involved in the biopharma industry, including CEOs and investors, published Wednesday promised to put the “interests of patients first.”

Pricing 52

Pricing Guide San Diego Company 52

socalTECH

JANUARY 20, 2015

San Diego-based biopharmaceuticals developer Tracon Pharmaceuticals said in a regulatory filing today that it is estimated its IPO pricing at between $12.00 The company--which filed for an IPO over the holidays--is looking to raised $57.96M on the NASDAQ Global Market as TCON. and $14.00 READ MORE>>.

San Diego 100

San Diego Acquisition Pricing Invest 100

socalTECH

OCTOBER 3, 2012

Prolific San Diego angel investor Howard Lindzon , who runs StockTwits , has scored a big exit at one of his portfolio companies, LifeLock , after the firm had its IPO this morning. Lindzon said it was an early angel investor in the company, and made his investment in 2006 at "well under a $10M valuation".

Symantec 133

Symantec San Diego Pricing Invest 133

socalTECH

OCTOBER 31, 2012

San Diego-based ServiceNow is looking to sell $300M in a secondary IPO offering, according to a filing made by the company Wednesday. ServiceNow went public in June, pricing at $18.00 The firm said it will not receive any proceeds from the sale by the selling stockholders. per share; the firm is now trading around $30.65

San Diego 138

San Diego Equity Pricing Sales 138

TechCrunch LA

DECEMBER 8, 2020

He did note that in the four markets where the company has gone live since launching its business in January 2019 — San Diego, Los Angeles, the Inland Empire , and Sacramento — has yielded an annualized revenue run rate of over $400 million in gross merchandise value (the total value of home sales transacted on its platform).

Sales 282

Sales Demand San Diego Funding 282

Xconomy

JULY 14, 2017

Akcea Therapeutics is joining the parade of biotechs going public, but the company had to cut its stock price and sell more shares in order to pull it off. But the biotech priced its offering of 15.6 million shares at $8 apiece, well below the $12 to $14 per share range that the company had initially set for an offering of 9.6

Pricing 57

Pricing Company Companies San Diego 57

Xconomy

APRIL 13, 2017

San Diego-based Tocagen (NASDAQ: TOCA ) priced its offering of 8.5 The company had previously planned to sell 7.25 million shares priced between $10 to $12 each. Tocagen has been developing a gene therapy treatment for a deadly type of brain cancer. million shares at $10 per share.

San Diego 66

San Diego Pricing Demand Marketing 66

Xconomy

SEPTEMBER 6, 2019

Being first to market with a new type of drug brings advantages. The first mover sets the bar for what physicians, payers, and patients can expect of that medicine and how much it costs. It grabs market share that followers have to steal away. But the first mover isn’t infallible if someone else has something better. is counting on.

Pricing 84

Pricing Class Study Marketing 84

socalTECH

JUNE 30, 2010

San Diego-based TargeGen , a firm developing small molecule kinase inhibitors for the treatment of myelofibrosis (MF) and polycythemia vera (PV), has been acquired by Sanofi-aventis, in a deal worth as much as $560M, the firm said Wednesday. Solomon Company in the deal. The firm was advised by Peter J.

Enterprise Partners 140

Enterprise Partners San Diego Acquisition Pricing 140

Xconomy

JANUARY 29, 2019

The New York-based startup said Tuesday that the new funding round, which is being led by Goldman Sachs Private Capital Investing group, brings its total investment to $35 million. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Product 90

Product Services Invest Pricing 90

socalTECH

JUNE 7, 2011

San Diego-based StockTwits , the real-time messaging service focused on the stock investing community led by Howard Lindzon, is aiming at the investors relation community with a new service. In particular, StockTwits has addressed some of the compliance concerns of public companies. READ MORE>>.

San Diego 140

San Diego News Pricing Ideas 140

Xconomy

DECEMBER 22, 2016

Founders of a company considering the various available fundraising options often ask the challenging question: Why take venture capital money, which may significantly dilute the founders and might result in a loss of control of the company? Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Pricing 40

Pricing Venture Capital Capital Networking 40

SoCal Tech Calendar

MAY 27, 2011

San Diego Tech Coast Angeles. Early Exits describes a strategy for startup investors and entrepreneurs to build a new ventures, prove business models and exit companies in 2-3 years without the need for multi-million dollar investments. Thursday, June 2, 2011 -- Early Exits.

Tech Coast Angels 100

Tech Coast Angels Venture Capital San Diego Pricing 100

Both Sides of the Table

SEPTEMBER 27, 2012

” In that post I talked about how a few key people in any community can have an enormous impact on the fledgling success of the city or company. Think USV is only invested around Union Square in NYC? Actually, there is tons of wealth in San Diego but it isn’t organized well to support them. Here are mine: 1.

Startup 378

Startup Venture Capital Press San Diego 378

Xconomy

MAY 9, 2019

It will be hard to top last year’s flurry of biotech companies joining the public markets, but this week is shaping up to be the busiest for life science IPOs in recent memory. Five biotechs priced their IPOs and at least one more is coming. To date in 2019, 23 healthcare-related companies have gone public, the most of any sector.

Pricing 110

Pricing Research Capital Marketing 110

Xconomy

JUNE 3, 2019

The La Jolla, CA-based company, which is developing protein drugs targeting cancer and other diseases, was founded in 2010. Read more about the company’s history and its recent $40 million financing round hedge fund Viking Global Investors here. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Funding 79

Funding Pricing Invest Develop 79

Xconomy

DECEMBER 14, 2018

Pharmaceutical industry critics lament the cost of rare disease drugs, but some of the steepest price hikes have come on widely used insulin. The patent holder, the University of Toronto, gave companies the right to manufacture insulin. to offer competitive pricing pressure. to offer competitive pricing pressure.

Patents 77

Patents Pricing Competition San Diego 77

Xconomy

JUNE 4, 2018

Bossa Nova, along with San Francisco-based Simbe Robotics, is among a group of tech companies that are using robotics and artificial intelligence. A combination of the sheer number of products a retailer like Walmart has on offer and the pace of 24/7 shopping makes it very difficult to maintain real-time inventories. “If

Artificial Inteligence 69

Artificial Inteligence Pricing Product San Diego 69

Xconomy

MAY 17, 2019

During his tenure as FDA commissioner, Scott Gottlieb often spoke about generics as a market force that could help tame climbing drug prices. But such tools only work when companies play fair. A lawsuit is now claiming that many top generic drug makers routinely conspired to avoid competition.

Pricing 79

Pricing Competition Tool Marketing 79

Xconomy

AUGUST 30, 2016

Petco, the privately held pet supplies company based in San Diego, said today it led a $10 million Series A financing in Los Angeles-based Petnet, a three-year-old startup developing technology-enabled pet feeders and pet food delivery service. million and now has about 30 employees, according to a spokeswoman for the company.

San Diego 52

San Diego Los Angeles Mobile Equity 52

Xconomy

SEPTEMBER 13, 2016

MedCrypt, a healthtech cybersecurity startup founded near San Diego, has raised $750,000 in a seed financing round led by Safeguard Scientifics (NYSE: SFE ), a private equity fund in suburban Philadelphia that invests in healthcare, fintech, and digital media. Jude’s stock price. Mike Kijewski.

San Diego 40

San Diego Startup Software Capital 40

Xconomy

MAY 2, 2019

The food technology company’s upsized IPO has raised $241 million to finance plans to bring its plant-based “meat” to more grocery stores and restaurants across the country. Beyond Meat priced its IPO Wednesday evening at $25 per share, which was the high end of its revised range. The El Segundo, CA-based company sold approximately 9.6

El Segundo 82

El Segundo Pricing Technology Venture Capital 82